Replies to post #27119 on BioCurex, Inc.(fka BOCX)

[Gold Seeker]

Sorry Half, you are wrong again. RECAF is an immunoassy, not a molecular test.

Per an investment presentation by Abbott, they plan to add 12 molecular tests in the next 2 to 3 years. No new immunoassy tests were even mentioned.